Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Cboe UK EUR

Pfizer Inc. (PFED.XC)

Compare
25.15
0.00
(0.00%)
At close: February 27 at 8:04:05 AM GMT

Research Analysis

Revenue vs. Earnings

Revenue 17.76B
Earnings 410M

Q1'24

Q2'24

Q3'24

Q4'24

0
5B
10B
15B
 

Analyst Price Targets

Earnings Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS --------

Revenue Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 12112120
Avg. Estimate 14.43B13.54B62.97B63.19B
Low Estimate 13.94B13.2B61.1B61.32B
High Estimate 15.25B13.88B64.59B65.5B
Year Ago Sales 14.88B13.28B63.63B62.97B
Sales Growth (year/est) -3.03%1.91%-1.03%0.35%

EPS Trend

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Current Estimate 0000
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
PFED.XC --------
S&P 500 16.00%7.22%10.60%14.10%

Upgrades & Downgrades

Reiterates Guggenheim: Buy to Buy 2/10/2025
Maintains Citigroup: Neutral to Neutral 1/28/2025
Maintains UBS: Neutral to Neutral 1/8/2025
Maintains Truist Securities: Buy to Buy 12/18/2024
Maintains Guggenheim: Buy to Buy 12/11/2024
Initiated Wolfe Research: Underperform 11/15/2024